Literature DB >> 33638761

Clinicopathological Profile of 80 Cases of Unicystic Ameloblastoma Aided by a Histopathological Comparison Using Modified Philipsen-Reichart Classification and Marx-Stern Classification.

Rahul Anand1, Anjali Narwal1, Deepak Pandiar2, Mala Kamboj1, Anju Devi1, Shikha Saxena3, Krishna Sireesha Sundaragiri3, Vijay Wadhwan4, Vandana Reddy4, Jiji George5.   

Abstract

Unicystic ameloblastoma (UA) is an uncommon variant of ameloblastoma and behaves totally different from the solid multicystic variant of ameloblastoma (SMA); furthermore the histological subgroups of UA also show varied behavior regarding proliferation. The present multi-centric study was designed to present the clinicopathological features of unicystic ameloblastoma (UA) and to compare the two popular histological classifications systems. 80 satisfactory cases of UA were retrieved and evaluated for clinicopathological parameters from four teaching dental schools of North India. The cases were classified using modified Reichart and Philipsen system and Marx and Stern system followed by comparison of inter-observer variability. The results were analyzed using SPSS software. The mean age of occurrence was 30.79 ± 16.49 years. Males outnumbered females (M:F::1.67:1). The majority of cases occurred in the third decade irrespective of the gender. Most cases were found in body-angle-ramus region of the mandible. The modified Reichart and Philipsen classification yielded better interobserver agreement (kappa value 0.845). The modified Reichart and Philipsen classification yields better inter-rater agreement and is easy to reproduce amongst oral pathologists. Being simpler it may easily be understood by the operating surgeon for better treatment outcome.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Ameloblastoma; Intraluminal; Luminal; Mural; Unicystic

Mesh:

Year:  2021        PMID: 33638761      PMCID: PMC8384931          DOI: 10.1007/s12105-021-01307-7

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  20 in total

1.  Unicystic ameloblastoma: a clinicopathologic study of 33 Chinese patients.

Authors:  T J Li; Y T Wu; S F Yu; G Y Yu
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  TUMORS OF THE JAW, ODONTOGENIC TISSUES AND MAXILLARY ANTRUM (EXCLUDING BURKITT LYMPHOMA) IN UGANDA AFRICANS.

Authors:  O G DODGE
Journal:  Cancer       Date:  1965-02       Impact factor: 6.860

3.  Histopathological features that predict the recurrence of odontogenic keratocysts.

Authors:  Hannah E Cottom; Faten I Bshena; Paul M Speight; Geoffrey T Craig; Adam V Jones
Journal:  J Oral Pathol Med       Date:  2011-11-16       Impact factor: 4.253

4.  Intraosseous ameloblastoma.

Authors:  Harvey P Kessler
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2004-08       Impact factor: 2.802

Review 5.  Ameloblastoma: biological profile of 3677 cases.

Authors:  P A Reichart; H P Philipsen; S Sonner
Journal:  Eur J Cancer B Oral Oncol       Date:  1995-03

6.  The unicystic ameloblastoma: a clinicopathological study of 57 cases.

Authors:  G L Ackermann; M Altini; M Shear
Journal:  J Oral Pathol       Date:  1988-11

Review 7.  Ameloblastoma in children.

Authors:  R A Ord; R H Blanchaert; N G Nikitakis; J J Sauk
Journal:  J Oral Maxillofac Surg       Date:  2002-07       Impact factor: 1.895

8.  Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma.

Authors:  T J Li; R M Browne; J B Matthews
Journal:  Histopathology       Date:  1995-03       Impact factor: 5.087

9.  Internal morphology of ameloblastomas: a study of 24 resected specimens.

Authors:  Sizakele P Ngwenya; Erich J Raubenheimer; Claudia E E Noffke
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-09-12

10.  Interrater reliability: the kappa statistic.

Authors:  Mary L McHugh
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.